Texas Gov. Greg Abbott Warns State Agencies About Potential Spying Risks from Chinese-Made Medical Devices
Texas Governor Greg Abbott has issued a direct warning to state health agencies and medical facilities about cybersecurity risks associated with Chinese-manufactured patient monitoring devices and other medical equipment, citing concerns that they could enable spying or data breaches by the Chinese Communist Party (CCP). In a letter dated March 9, 2026, Abbott directed the Texas Health and Human Services Commission (HHSC), Department of State Health Services (DSHS), and public university systems to immediately review their procurement policies and cybersecurity measures to safeguard Texans’ personal medical data and critical infrastructure.
The directive emphasizes protecting “Texans’ physical security and personal privacy, especially personal medical data,” which Abbott described as a “paramount importance.” He stated, “I will not let Communist China spy on Texans. State-owned medical facilities must ensure there are safeguards in place to protect Texans’ private medical data and our critical medical infrastructure.” The order references prior federal alerts, including warnings from the U.S. Food and Drug Administration (FDA) in previous years about vulnerabilities in certain foreign-made medical devices that could allow unauthorized access or data exfiltration.
This move fits into Abbott’s broader ongoing campaign to restrict technologies linked to the People’s Republic of China (PRC) and CCP on state systems. Texas has progressively expanded its prohibited technologies list—managed by the Texas Cyber Command—to include AI tools, social media apps, hardware from companies like Alibaba, Shein, TP-Link, and others. Recent updates (e.g., January 2026) added restrictions on physical hardware, software, and AI affiliated with China, driven by fears of data harvesting, surveillance, and exploitation by hostile foreign actors.
The latest focus on medical devices highlights potential vulnerabilities in healthcare settings, where patient monitoring equipment (e.g., devices for vital signs, telemetry, or imaging) could theoretically transmit sensitive health information back to manufacturers or third parties. While no specific brands or incidents were named in Abbott’s letter, the warning aligns with national security concerns about supply-chain risks in critical infrastructure, including hospitals and state-run clinics.
Public reactions have been supportive in conservative circles, with many on social media praising Abbott for proactive defense against foreign espionage. Comments often tie it to broader U.S.-China tensions, including trade restrictions and cybersecurity threats. Critics, however, question whether blanket scrutiny of Chinese-made devices could disrupt supply chains or increase costs for Texas healthcare providers already facing shortages.
For Texas residents, this could lead to shifts in hospital procurement—potentially favoring U.S. or allied-nation manufacturers—to comply with state directives. It also underscores ongoing debates about balancing security, affordability, and access to medical technology in a state with a large public health system.
Here are some key images from the announcement and related coverage, including Abbott’s letter excerpt, Texas state seal visuals, and graphics on prohibited tech lists:
This directive is the latest in Abbott’s series of executive actions hardening Texas against perceived CCP threats, following bans on apps like TikTok (2022) and expansions to hardware/AI in 2025–2026. State agencies are expected to report back on their reviews, with potential updates to procurement guidelines forthcoming. If you’re in Texas healthcare or tracking cybersecurity policy, keep an eye on HHSC/DSHS announcements for implementation details. Let me know if you want more on the federal FDA context or similar actions in other states!











